Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Literature
1.
Mont MA, Carbone JJ, Fairbanck AC (1996) Core decompression versus nonoperative management for osteonecrosis of hip. Clin Orthop 324:169–178PubMedCrossRef
2.
Glimcher MJ, Kenzora JE (1979) The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; comments on treatment. Clin Orthop 312
3.
Little DG, McDonald M, Sharpe IT, Peat R, Williams P, McEvoy T (2005) Zoledronic acid improves femoral head sphericity in a rat model of Perthes disease. J Orthop Res 23:862–862PubMedCrossRef
4.
Adami S, Bevilacqua M, Broggini M et al (2002) Short-term intravenous therapy with neridronate in Paget’s disease. Clin Exp Rheumatol 20:55–58PubMed
5.
Cascella T, Musella T, Orio F Jr et al (2005) Effects of neridronate treatment in elderly women with osteoporosis. J End Invest 28:202–208
6.
Braga V, Gatti D, Colapietro F et al (2003) Intravenous neridronate in the treatment of postmenopausal osteoporosis. Bone 33:342–345PubMedCrossRef
7.
Fromigue O, Body JJ (2002) Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Invest 25:539–546PubMed
8.
Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363–1374PubMedCrossRef
9.
Agarwala S, Sule A, Pai BU, Joshi VR (2002) Alendronate in the treatment of avascular necrosis of the hip. Rheumatology 41:346–347PubMedCrossRef
10.
Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM (2005) The use of alendonate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. J Bone Joint Surg Am 87:2155–2159PubMedCrossRef
11.
Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H (2006) Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res 443:273–279PubMedCrossRef
12.
Kim HK, Randall TS, Bian H, Jenkins J, Garces A, Bauss F (2005) Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am 87:550–557PubMedCrossRef
Metadata
Title
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report
Authors
A. Corrado
L. Quarta
S. Errico
F. P. Cantatore
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0306-9

Other articles of this Issue 9/2007

Rheumatology International 9/2007 Go to the issue

Case Report

Hysterical paralysis

Case Report

Successful treatment of hepatitis B-associated leukocytoclastic vasculitis with lamivudine treatment in a child patient

Original Article

Assessment of fatigue in patients with ankylosing spondylitis

Original Article

P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters

Case Report

A 30-year result of deforming arthritis in systemic lupus erythematosus

Original Article

Ocular surface and intraocular inflammation are related in SS-I and rheumatoid arthritis patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits